SCHEMBL24591799

SCHEMBL24591799

CC(C)(C)N[C@@H](CCCCNC(N)=O)C(=O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT6 Q8N6T7 1/20 0.35
▸ SIRT1 Q96EB6 1/20 0.35
▸ FOLH1 Q04609 1/20 0.33
▸ C3AR1 Q16581 1/20 0.33
▸ DPP7 Q9UHL4 2/20 0.33
▸ SIRT5 Q9NXA8 1/20 0.32
▸ GNAI3 P08754 1/20 0.32
▸ GNAO1 P09471 1/20 0.32
▸ GNAI1 P63096 1/20 0.32
▸ MAOA P21397 1/20 0.32
▸ MAOB P27338 1/20 0.32
▸ EPHX1 P07099 1/20 0.32
▸ MEN1 O00255 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ALB P02768 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ HIF1A Q16665 1/20 0.31
▸ RRM1 P23921 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21152809 0.97 C3AR1 (0.35) SIRT6SIRT1FOLH1C3AR1MEN1
SCHEMBL19483434 0.88 ALOX15 (0.36) SIRT6SIRT1FOLH1DPP7SIRT5
SCHEMBL19483435 0.88 ALOX15 (0.36) SIRT6SIRT1FOLH1DPP7SIRT5
SCHEMBL19483322 0.85 KDM4E (0.48) SIRT6SIRT1FOLH1SIRT5EPHX1
SCHEMBL27424230 0.85 POLB (0.41) SIRT6SIRT1FOLH1EPHX1MEN1
SCHEMBL19483324 0.85 KDM4E (0.48) SIRT6SIRT1FOLH1SIRT5EPHX1
SCHEMBL4572264 0.84 NPY4R (0.36) SIRT6SIRT1MEN1GAAKMT2A
SCHEMBL26880961 0.84 NPY4R (0.36) SIRT6SIRT1MEN1GAAKMT2A
SCHEMBL22068109 0.84 FURIN (0.33) SIRT6SIRT1SIRT5KMT2A
SCHEMBL27016037 0.83 KMT2A (0.39) SIRT6SIRT1FOLH1DPP7GNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11377502-B2 Anti-MSR1 antibodies and methods of use thereof REGENERON PHARMACEUTICALS, INC. (US) 2022-07-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11377502-B2 Anti-MSR1 antibodies and methods of use thereof CD47, MSR1, LDLR SIRT6 3364/4885SIRT1 4116/4885FOLH1 634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback